Pfizer Attacks 'False' Biosimilar Info, Urges FDA Action
Major biotech companies have smeared biosimilars in "false and misleading" ways that have undermined the copycat products and perhaps flouted federal law, Pfizer Inc. charged in a petition released Monday calling...To view the full article, register now.
Already a subscriber? Click here to view full article